Posted in M&A / Deals Aligos and Xiamen Amoytop sign deal for HBV therapy April 17, 2026 Pharmaceutical Technology Aligos Therapeutics and Xiamen Amoytop Biotech are to develop and commercialise pevifoscorvir sodium in Greater China for chronic HBV infection. M&A / DealsRead full story